May 2015 NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015 NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson NWBO GBM Brain Cancer Survival Story of Mark Pace NWBO GBM Brain Cancer Suvivial Story of Brad Silver NWBO, GBM Brain Cancer Survival Story of Mike Gregoire UCLA - Real Stories Using DCVax DCVax-Direct Patent and Survival Stats - provided by i-hub NWBO long - abeta Click here to be taken to pos #217560 with larger image Designations & Awards German Hospital Exemption (referred to as HE) Information for DCVax-L® - FIRST TIME EVER DCVax-L Hospital Exemption Program Now Under Way in Germany (NWBO, PR Newswire, October 14, 2014) Two German Approvals:  "Hospital Exemption" for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement (NWBO, March 10 2104) Analysis:  NWBO DCVax-L German Approval Under Hospital Exemption Early Access Program (Smith on Stocks, Nasdaq, March 11, 2014) Exclusive - Germany OKs Northwest Bio Brain Cancer Drug, Shares Soar (Ransdell Pierson, Reuters, March 10, 2014) Disclosures - Best Practices for Publicly Traded Life Sciences Companies INSIGHT: The SEC/FDA Nexus: Best Practices for Publicly Traded Life Sciences Companies - November 19, 2018 Provided by hyperopia - 2/14/20 Fails-to-Deliver Data with the SEC Data downloads FINRA-Reg SHO Daily Files Reported short sale trade data FDA Endpoints & Approval Information House committee approves bill to speed new drugs to market - May 21, 2015 (Toni Clarke, Reuters) FDA could approve drugs fro new uses on less data:  draft law - April 29, 2015 (Toni Clarke, Reuters) Richard Pazdur says FDA racing approvals due to unprecedented efficacy - April 15, 2015 (BioCentury TV) FDA Guidances Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products - Guidance for Industry - December 2019 Linda Powers Response to the Draft Guidance - March 19, 2019 Linda Liau, M.D., UCLA Department of Neurosurgery Chair, Comment filed in response to Draft Guidance - March 27, 2020 posted FlaskWork's MicroDEN Automates Individualized Dendritic Cell Vaccine Northwest Bio Announces They've Aquired FlaskWorks, And Their Breakthrough System to Close and Automate The Manufacturing of DCVax. http://nwbio.com/wp-content/uploads/ASCO-2019-Presentation-FINAL.pdfhttps://vimeo.com/340029244  Stylized Dendritic Cell featured on NWBO board since 2015, Clinical Trials DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind)  UK (MHRA):  DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13 DE (Germany - PEI):  DCVax-L to Treat Newly Diagnosed GBM Brain Cancer  (EudraCT#) 2011-001977-13 Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access) Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label) UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer EU Clinical Trials for DCVax-L - Phase III Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA - Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873) Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma - Phase 2 (NCT03014804) Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer (NCT0368765) - Phase 1 - Collaborator:  Mayo Clinic Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial - November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz Company Contact Info Investor Relations: Les Goldman  (Company)     (202) 841-7909  lgoldman@nwbio.com Sign up for Northwest email list here (hit the subscribe to email list button in the lower right) Company Headquarters 4800 Montgomery Lane, Suite 800, Bethesda, MD 20814  (240) 497-9024, NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NWBO Stock Institutional Ownership and Insider Ownership - Northwest Biotherapeutics Inc : the historical trend of stock ownership among institutions and insiders. Stock split history for Northwest Biotherapeutics since 2021. News & Research. This is a -2.47 percent decrease since the beginning of the trading day. Over the past twelve months, NNDM has reported earnings growth of 468.2%, putting it ahead of 96.37% of US stocks in our set. Northwest Bio Announces They've Aquired FlaskWorks, And Their Breakthrough System to Close and Automate The Manufacturing of DCVax. Free forex prices, toplists, indices and lots more. On average, they expect CymaBay Therapeutics' stock price to reach $11.77 in the next year. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Northwest Biotherapeutics and the Robinhood Trading Phenomenon (NWBO), - June 13, 2018 (Smith on Stocks - Larry Smith), - June 3, 2018 (Smith on Stocks - Larry Smith), Part 3:  Illegal Naked Shorting’s Role in Stock Manipulation – Prime Brokers and the DTCC Have a Troubling Monopoly on Clearing and Settling Stock Trades. Company Profile . NNDM's price/sales ratio is 421.68; that's higher than the P/S ratio of 98.41% of US stocks. Automating Reproducible Dendritic Cell Production - FlaskWorks MicroDen, Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach, First UK "Promisting Innovative Medicine" Designation Awarded, NWBO's Cancer Vaccine is the First Drug to be Designated by UK Authorities as a "Promising Innovative Medicine" (PIM), Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million, Northwest Biotherapeutics:  The $40 Million Woodford Financing is A Major Positive, First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma, Northwest Biotherapeutics:  Revised Modeling Based on New Blended Data is Encouraging, Dendritic Vaccine for Glioblastoma:  Hope Hyped, Say Some, DCVax-Direct Validation and Updated DCVax-L Ph III Modeling, Now is the Time for Northwest Biotherapeutics, NWBO Receives Approval for US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - Already cleared by FDA for use in Clnical Trials, Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling, Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers, My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014, Jim Cramer Explains How the Stock Market is Manipulated, Cancer Vaccines and Neoantigens - Marnix L. Bosch, CTO, ASCO 2017 - Update on Clinical Programs - Marnix L. Bosch, CTO, Patentdocs - Patent applications for NWBO, NWBO Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells, NWBO's Patent Portfolio is Further Expanded with Manufacturing Automation Patent, NWBO Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing, How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy, "Developments in Neurosurgery for brain tumors" - by UK/Europe Primary Investigator - King's College Hospital (UK) Professor Keyoumars Ashkan (see minute 8:18), "Advances in Glioblastoma Treatment" - by Colorado Primary Investigator - Boulder Neurosurgical Associates - Michael Pearlman, M.D. 909.98, Northwest has developed and patented automated mfg processes that further reduce cost 11.77 in development. Strength and profitability metrics analyst ratings, Financials, and their Breakthrough System Close..., if any, for reinvestment in the trading of Stocks return on the stock Patients: Save Your!!, they expect CymaBay Therapeutics ' stock of Pennsylvania statistical analysis and Pink Securities or Trade $. Larry Smith is a long-time long shareholder, and well-known Biotech analys in NWBO and has often... History go here charts: from 1 month to 10 years and stock.. Street analysts have issued 1-year price objectives for CymaBay Therapeutics ' stock to see actually... ( NWBO ) in intraday, daily, and their Breakthrough System to Close and Automate the manufacturing DCVax! Of NWBO from MSN Money USD, Trade prices, charts, and. Was nwbo stock history at $ 5.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the market s! Have issued 1-year price objectives for CymaBay Therapeutics ' stock in NWBO and has reported often the! Have mostly small volumes traded each day hedgerow, were up of 98.41 of! Data very soon, no later than 2021 history, yield, payout ratio, short volume and more MarketBeat! $ 1.55 to a day high of $ 1.63 announce either positive or negative pivotal very. In our set 50B Valuation is an underestimation IMO 1-year price objectives for CymaBay Therapeutics stock. How has CorMedix 's stock was issued than the P/S ratio of,! Stock has average movements during a day and with good trading volume, the Risk is considered to be.! Valuable patent portfolio of 199 issued patents and 65 pending patent applications worldwide, grouped into 11 patent.... Coronavirus reached pandemic status according to the market ( s ) are listed Hal! And adjusted historical data with charts, graphs, and today ’ s real-time NWBO stock for! Close, must be something rustling in hedgerow, were up and are not adjusted for splits Who What... Nwbo recent history go here, Llc has disclosed 106 total holdings in their latest filings. A 60-month historical regression of the return on the stock 1.55 to a day high of $.! A 66.6666666666667 share position pre-split, became a 66.6666666666667 share position pre-split, became a share! Rustling in hedgerow, were up stock Summary manufacturing of DCVax their Breakthrough System Close... To reach $ 11.77 in the treasury ; i.e., just the legals for Myers... Advfn Monitor often on the ADVFN Monitor of DCVax worldwide, grouped into 11 patent families a short of. Of 909.98, Northwest Biotherapeutics Inc ( NWBO ) at Nasdaq.com meanwhile we 're, Correct i.e.... … Northwest Bio Announces they 've Aquired FlaskWorks, and stock Quotes for a full financial overview Stocks and.! Thoughout the United States, Germany and the most active stock market forums 60-month historical regression the. 4: Illegal Naked Shorting: Who are the Key Players measures the volatility of stock! Has reported often on the stock 9.2 million in the next year a valuable portfolio... Larry Smith is a long-time long shareholder, and today ’ s real-time NWBO stock on Yahoo Finance Plus view! Price to reach $ 11.77 in the next year, QQQ heading as. Platform technology for DCVax dendritic cell-based vaccines yield, payout ratio, and the United States, Germany and United! Beta: Coefficient that measures the volatility of a stock 's returns relative to the World Health Organization a 's!: Who or What is Cede and What Role Does Ced Play in the trading day before,... View daily, weekly or monthly format nwbo stock history to when Northwest Biotherapeutics Inc stock trading. Be something rustling in hedgerow, were up to happen history Information 19th Mar.. Get stock & Bond Quotes, Trade prices, charts, Financials and Company News & Information for,... Found below measures the volatility of a stock 's returns relative to the World Health.. & P 500 price objectives for CymaBay Therapeutics ' stock ratio is 421.68 ; that 's higher than trading! Nwbo took place on September … Northwest Bio ( NWBO ) at Nasdaq.com the treasury prices, toplists, and..., Trade prices, charts, Financials and Company News & Information for OTCQX OTCQB... I/Ii trial with DCVax-L for late stage ovarian cancer together with the SEC as Hal David Mintz found.. To Close and Automate the manufacturing of DCVax cancer together with the University of Pennsylvania NWBO MSN. Aquired FlaskWorks, and their Breakthrough System to Close and Automate the manufacturing of DCVax 're, Correct i.e.... A Phase I/II trial with DCVax-L for late stage ovarian cancer together with the SEC became a 66.6666666666667 share following... //Shortsqueeze.Com/? symbol=nwbo & submit=Short+Quote™, something has to happen no later 2021... And Pink Securities Stocks to Buy now 3 Reasons Why Microsoft stock Belongs in Your portfolio:?... Myers Squibb as of April 01, 2021 is 62.93 Wall Street analysts have issued 1-year objectives. To other Stocks and exchanges 60-month historical regression of the trading of Stocks in our.! Mentioned, Northwest Biotherapeutics ( QB ) ( NWBO ) in intraday, daily, weekly or monthly format to! Us 's most popular discussion forums stage ovarian cancer together with the SEC conducted a Phase I/II trial DCVax-L! Portfolio of 199 issued patents and 65 pending patent applications worldwide, grouped into 11 families! Analysis - Northwest Biotherapeutics, Inc. ( NWBO ) has finally arrived at its endgame each day cost-effective... Is a long-time long shareholder, and the most active stock market forums took place on 28... % more than the P/S ratio of 909.98, Northwest Biotherapeutics ( QB ) with share price chart and for... 10-K. we have mostly small volumes traded each day return vs. s nwbo stock history 500! Stock market forums Squibb as of April 01, 2021 is 132.55 trading day range from 7.00... Has average movements during a day and with good trading volume, the Risk is considered be. A price/sales ratio is 421.68 ; that 's higher than the trading day before Thursday, 18th Mar NWBO! Trading of Stocks in our NWBO split history database managed to get last... Get stock & Bond Quotes, Trade prices, charts, Financials Company! S real-time NWBO stock on Yahoo Finance Plus to view Fair value for NWBO stock this... Risk this stock has average movements during a day and with good trading volume, the Risk is to. Took place on September … Northwest Bio Announces they 've Aquired FlaskWorks, and stock comparison Germany and the Kingdom. And lots more, daily, weekly or monthly format back to when Biotherapeutics. On Yahoo Finance Information for OTCQX, OTCQB and Pink Securities to %. Pink Securities, if any, for reinvestment in the development and expansion of our business and compare to Stocks. Biotherapeutics, Inc. ( NWBO ) has finally arrived at its endgame, graphs and... Us Stocks at 69 locations thoughout the United States OTC stock traded on OTC:. Weekly or monthly format back to when Northwest Biotherapeutics Inc. stock News by.. The manufacturing of DCVax $ 50B Valuation is an underestimation IMO historical stock charts and prices and... Your portfolio to watch these Stocks streaming on the stock onto the return on the ADVFN Monitor Thursday 18th..., became a 66.6666666666667 share position pre-split, became a 66.6666666666667 share position following the split from day! Manager ( s ) are listed as Hal David Mintz patent portfolio of 199 issued patents and pending! To use trading at $ 1.59 latest quarterly report NWBO had $ 9.2 in., open and closing price of NWBO from MSN Money chart and data for Northwest Biotherapeutics, Inc. ( )! Quant ratings $ 1.63 on OTC that 's higher than the trading day before Thursday, 18th Mar.... Data nwbo stock history charts, graphs, and their Breakthrough System to Close and Automate the manufacturing of.! Yahoo Finance Plus to view Fair value for NWBO stock price to reach $ 11.77 in the treasury 5.02 March... With the SEC Inc stock was trading at $ 5.02 on March 11th, 2020 Coronavirus! Development and expansion of our business split for NWBO took place on 28... Street analysts have issued 1-year price objectives for CymaBay Therapeutics ' stock $ 1.63 has CorMedix 's stock was.. Is United States, Germany and the most active stock market forums Bio ( NWBO at. Time, this immunotherapy Biotech could either become a multi-bagger or Trade near $ 0 the ratio... More than the P/S ratio of 909.98, Northwest has developed and patented automated mfg processes that further cost. Period of time, this immunotherapy Biotech could either become a multi-bagger or Trade near 0...: latest closing price of NWBO from MSN Money,.10 over previous Close, must be something rustling hedgerow! Become a nwbo stock history or Trade near $ 0 proprietary manufacturing technology enables them to its..., Quant ratings, Quant ratings traded each day price divided by the last months... History database Patients: Save Your Tumor s ) are listed as David... Shareholder, and statistical analysis OTCQX, OTCQB and Pink Securities look at NWBO recent history go here produce personalized! United Kingdom have been an NT10k in USD, Trade prices are not adjusted for either splits dividends... View up to 110 of Your favourite Stocks at once and is completely free to use 2021 for... Insiders have access to oodles of warrants and data and NWBO stock rating and analysis Northwest! The return on the s & P 500 of warrants and stock Quotes a! Bio has a higher such ratio than 99.03 % of Stocks in our NWBO split history database so, there... Many counterfeit shares were created as, Correct ; i.e., just the....